. Yet the capacity of the fetal immune system, including antigen-presenting cells, to detect and respond to such stimuli remains unclear. In particular, dendritic cells, which are crucial for effective immunity and tolerance, remain poorly characterized in the developing fetus. Here we show that subsets of antigen-presenting cells can be identified in fetal tissues and are related to adult populations of antigen-presenting cells. Similar to adult dendritic cells, fetal dendritic cells migrate to lymph nodes and respond to toll-like receptor ligation; however, they differ markedly in their response to allogeneic antigens, strongly promoting regulatory T-cell induction and inhibiting T-cell tumour-necrosis factor-α production through arginase-2 activity. Our results reveal a previously unappreciated role of dendritic cells within the developing fetus and indicate that they mediate homeostatic immune-suppressive responses during gestation.
. Yet the capacity of the fetal immune system, including antigen-presenting cells, to detect and respond to such stimuli remains unclear. In particular, dendritic cells, which are crucial for effective immunity and tolerance, remain poorly characterized in the developing fetus. Here we show that subsets of antigen-presenting cells can be identified in fetal tissues and are related to adult populations of antigen-presenting cells. Similar to adult dendritic cells, fetal dendritic cells migrate to lymph nodes and respond to toll-like receptor ligation; however, they differ markedly in their response to allogeneic antigens, strongly promoting regulatory T-cell induction and inhibiting T-cell tumour-necrosis factor-α production through arginase-2 activity. Our results reveal a previously unappreciated role of dendritic cells within the developing fetus and indicate that they mediate homeostatic immune-suppressive responses during gestation.
We used a combination of flow cytometry and gene array analysis to characterize human fetal antigen-presenting cells (APC) and compare them with adult APC. Using our previously described gating strategy for adult tissue APC 7, 8 (Extended Data Fig. 1a , b), we identified fetal APC subsets: CD14 + monocytes/macrophages, plasmacytoid dendritic cells (pDC), conventional (c)DC1, and cDC2 within fetal spleen, skin (in agreement with findings by others 9 ), thymus, and lung (Fig. 1a and Extended Data Fig. 1a ) by 13 weeks estimated gestational age (EGA). Within both early (12-15 weeks) and late (16-22 weeks) secondtrimester fetal tissue, APC were relatively abundant within the CD45 + compartment compared with adult tissues (Fig. 1b and Extended Data Fig. 1c) . Fetal spleen cDC1 and cDC2 were also observed in situ using immunofluorescence microscopy (Extended Data Fig. 1d ). Next we compared the gene expression profiles of cDC1, cDC2, and CD14
+ cells from fetal skin and spleen with those from adult spleen (for sort gating strategy, see Extended Data was used to compare the subset-specific gene expression signatures of fetal spleen and skin cDC1, cDC2, and CD14
+ cells with those of adult blood, skin, and spleen APC (Fig. 1c) . Connectivity map scores indicated that the gene expression signature of fetal cDC1 was enriched with genes also expressed by adult cDC1; similarly, the fetal cDC2 signature was enriched with adult cDC2-associated genes and fetal CD14
+ cells scored most highly with adult blood monocyte and tissue macrophage populations, as expected 7, 8 . Scatter plot analysis of normalized gene expression confirmed the strong correlation (R = 0.92) between the expression profiles of fetal and adult cDC1, as well as fetal and adult cDC2 (Extended Data Fig. 2b ). Conserved gene lists across fetal and adult APC subsets and ingenuity pathway analysis of these gene lists are provided in Supplementary Tables 1-9 (see Supplementary Experimental Procedures for the analysis). At the molecular level, fetal and adult dendritic cells expressed comparable levels of dendritic cell subset-specific transcription factors (Extended Data Fig. 2c ), in agreement with published data 10 . Detailed phenotyping by CyTOF and One-SENSE analysis (see Supplementary Experimental Procedures and ref. 11 ) demonstrated that fetal and adult spleen dendritic cells had similar antigen expression profiles, except for CD141, Fcε R1, and CLA, which were relatively more highly expressed on adult cDC2 (Extended Data Fig. 4a, b) .
To gain insight into the functions and heterogeneity of the fetal tissue cDC populations, we first compared their surface antigen expression profiles across tissues within single donors ( Fig. 2a ; input gating strategy and original heatmap in Extended Data Fig. 5a , b), and with cDC from adult tissues using CyTOF and One-SENSE analysis 11 (Extended Data Fig. 5c ). Fetal cDC1 and cDC2 showed great heterogeneity between tissues at the single-cell level (Fig. 2a) , most obviously within the lung, suggesting differential tissue imprinting. We also identified tissue-specific cDC phenotypes conserved between adults and fetuses (Extended Data Fig. 5c ). For example, both fetal and adult lung cDC2 expressed elevated levels of CD2 and Fcε R1, while expression of these markers by fetal and adult gut cDC were low to negative. Notably, the fetal lung cDC2 population exhibited heterogeneous expression of the transcription factor interferon-regulatory factor (IRF)-4 (Extended + , cDC1, and cDC2 cells were identified within fetal spleen and skin by flow cytometry. b, Enumeration of APC subsets within fetal and adult tissues. MannWhitney test * P < 0.05, * * P < 0.01, * * * P < 0.001. Mean ± s.e.m. c, Connectivity map (CMAP) enrichment scores for fetal skin and spleen cDC1, cDC2, and CD14 + cells against all adult blood, skin, and spleen APC subsets are shown. Enrichment scores for fetal skin and spleen cDC1, cDC2, and CD14
+ cells with equivalent adult APC subsets were significant at P < 0.0001. a, b, Each data point in the scatter plots represents an individual experiment. Data Fig. 5d ), which indicated contamination of the gated population with monocytes and/or monocyte-derived cells, as seen in adults 12 . Several activation markers were differentially expressed between cDC from different fetal tissues. In particular, fetal gut cDC displayed a more activated phenotype than did cDC in other fetal tissues (Fig. 2 a and Extended Data Fig. 5b, c) , expressing higher levels of the chemokine receptor CCR7 and the activation markers CD80 and CD86. As CCR7 mediates dendritic cell migration to lymph nodes in adults, where they initiate and shape emergent T-cell responses 8, 13 , we then asked whether CCR7
+ gut dendritic cells migrated to their draining lymphoid organs during fetal life. Using a gating strategy verified in adult tissues (Fig. 2b) . In contrast, in the fetal appendix and tonsil, which lack connecting afferent lymphatics, we observed only resident dendritic cells (Fig. 2b) . Within the MLN, the resident cell population included CD14 Data Fig. 6a ). The migratory-phenotype fraction of dendritic cells within the MLN contained relatively few CD14
+ cells, as in adults 7, 8 , alongside both cDC1 and cDC2, with the former relatively more abundant (Extended Data Fig. 6a, b) . Of note, fetal gut cDC1 expressed more CCR7 than did cDC2 (Extended Data Fig. 5c ). Similar to adult migratory dendritic cells 7 , fetal MLN migratory dendritic cells expressed higher levels of CCR7 and the activation markers CD80, CD83, and CD86 than did dendritic cells with the resident phenotype (Extended Data Fig. 6c ). Looking along the timeline of the second trimester of gestation, we found that while 14-15 week EGA MLN contained abundant resident dendritic cells, migratory dendritic cells were scarce or absent (Fig. 2c, d ), suggesting that fetal gut dendritic cells begin migrating to the MLN from 16 to 17 weeks EGA. The presence of migratory dendritic cells in the MLN is consistent with expression of the lymph-node-homing cytokines CCL19 and CCL21 (ref. 14) in the fetal gut and MLN (Extended Data Fig. 6d, e) . Migratory HLA-DR + cells were also visualized within the lymphatic vessels (LYVE-1 + ) of 17-22 week EGA fetal skin (Extended Data Fig. 6f and ref. 8 ), providing confirmation that fetal cDC can migrate via lymphatic vessels in vivo. Furthermore, we observed fetal dendritic cells migrating out of skin explants over a period of 48 h (Extended Data Fig. 6g ), using ex vivo skin assays validated in adult tissues 15 . In summary, our data suggest that fetal skin and gut dendritic cells have the capacity to migrate through lymphatics and to lymph nodes from 16 weeks EGA, where they may interact with fetal T cells that are present in lymphoid organs from 10 weeks EGA 16 . The reason for the initiation of dendritic cell migration to the lymph nodes around 16 weeks EGA remains unclear: while the human lymphatic system is in place by 8 weeks EGA, it may remain functionally immature for some time thereafter 17 . Next, we asked whether fetal cDC were able to respond toll-like receptor (TLR) 18 stimulation and/or to activate naive T cells in vitro. Sorted splenic cDC2 (most abundant cDC subset) from 17 to 22 week EGA fetuses and adult samples were exposed to a panel of TLR agonists: adult and fetal cells secreted similar amounts of the pro-inflammatory cytokines GM-CSF, IL-6, IL-8, and MIP-1β ( Fig. 3a and Extended Data Fig. 7a ), in line with their similar expression of pattern recognition receptors (Extended Data Fig. 7b ). Moreover, fetal and adult splenic cDC2 induced comparable proliferation of allogeneic carboxyfluorescein succinimidyl ester (CFSE)-labelled adult splenic T cells in a mixed lymphocyte reaction (Fig. 3b) . Thus fetal cDC are capable of both sensing pathogens and stimulating T cells, which, together with their migratory ability, indicates that they have the potential to initiate an immune response to microbe-derived products around 17 weeks EGA.
While this shows that fetal cDC are capable of initiating allogeneic T-cell proliferation in vitro, we know that lifelong in vivo tolerance towards non-inherited maternal allogeneic antigens is established during gestation 2,9,19 . Thus, to understand how fetal dendritic cells contribute to such tolerogenic T-cell responses, we examined the phenotype of the T-cell populations generated from mixed lymphocyte reaction, where fetal or adult cDC2 were co-cultured with allogeneic adult spleen T cells. After co-culture for 6 days, fetal spleen cDC2 induced the differentiation of significantly higher frequencies of CD4
+ bona fide T regulatory cells (T reg ) 1,20,21 than did adult splenic cDC2 (Extended Data Fig. 8a-c) . Confirming the immunosuppressive capacity of fetal cDC2-induced ), CpG oligodeoxynucleotides (CpG) (3 μ M), polyinosinic-polycytidylic acid (PI:C) (25 μ g ml −1 ), peptidoglycan (PGN) (10 μ g ml −1 ), lipopolysaccharide (LPS) (0.1 μ g ml −1 ) + CD40 ligand (CD40L) (1 μ g ml −1 ). No stim., no stimulation. Mean ± s.e.m., n = 4. b, Alloactivation of adult CD4 + T cells by fetal and adult cDC2 after co-culture for 6 days. Proliferation was measured by CFSE dilution. Left: representative histograms. Right: cumulative data, n = 5. Mean ± s.e.m. NS, not significant (P > 0.05), Mann-Whitney test.
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T reg cells, CD8
+ T-cell proliferation was significantly impaired upon co-culture with fetal cDC2 as opposed to adult cDC2 (Extended Data Fig. 8d) , and was restored when CD4 + T cells were removed (Extended Data Fig. 8e ). In addition, allogeneic T cells cultured with fetal cDC2 (Fig. 4a ) or cDC1 (Extended Data Fig. 8f ) produced significantly less of several pro-inflammatory cytokines and significantly more of the Th2-polarizing cytokine IL-4, but not IL-13, compared with allogeneic T cells incubated with adult cDC2. Thus, consistent with the establishment of fetal tolerance to maternal antigens in vivo, fetal cDC initiate T reg induction and do not launch T-cell pro-inflammatory responses in vitro.
The observed functional differences between fetal and adult dendritic cells were mirrored at their gene expression level, with over 3,000 genes being significantly differentially expressed between fetal and adult APC (Extended Data Fig. 9a and Supplementary Tables 10 and 11 ).
Ingenuity pathway analysis revealed that multiple pathways involved in educating T cells were significantly differentially regulated between fetal and adult APC, as were several pathways involved in the inducible nitric oxide synthase/tumour-necrosis factor-α (iNOS/TNF-α ) axis (Extended Data Fig. 9b , red and black arrows, respectively, Supplementary Table 12 ). Further analysis revealed that a number of genes involved in immune suppression/inflammation were differentially expressed (Extended Data Fig. 9c ). Of particular interest was the elevated expression of arginase-2 by fetal spleen cDC2 (Fig. 4b, c ) and cDC1 (Extended Data Fig. 9d , e) in comparison with adult spleen cDC. Of note, arginase-2 expression was not modulated by TLR stimulation (Extended Data Fig. 9f ). Arginase depletes the local environment of l-arginine (by converting l-arginine to l-ornithine and urea) which is required for the production of TNF-α 22, 23 . Importantly, arginase activity has been shown to be an essential player in the regulation of TNF-α levels in the neonate 22 . Coincidingly, we found that in stimulated splenic culture (that is, include APC), fetal T cells did not produce TNF-α compared with adult T cells (Fig. 4d and Extended Data Fig. 10a ). However, when enriched (that is, in the absence of APC), they produced TNF-α , although to a lesser level to their adult counterparts (Fig. 4d) . Furthermore, we found significantly lower frequencies of fetal T cells producing TNF-α than adult T cells after 6 days of culture (Extended Data Fig. 10b ). In addition, when fetal and adult splenocytes were co-cultured at increasing ratios of fetal cells, adult T-cell TNF-α production was impaired. While fetal splenocytes also promoted T reg induction, the change in TNF-α levels did not correlate with the change observed in T reg induction (Extended Data Fig. 10b-d ). These data suggested that the differential arginase-2 expression between adult and fetal cDC is sufficient to regulate T-cell responses and their TNF-α production.
In the absence of any cDC, approximately 24% of proliferating adult splenic T cells produced TNF-α , while after co-culture for 6 days with fetal cDC2 (Fig. 4e , f) or cDC1 (Extended Data Fig. 9g ) expressing arginase-2, their ability to produce TNF-α was dramatically reduced. TNF-α production was reinstated upon replenishing the medium with l-arginine or by the addition of arginase-specific inhibitors 22 (Fig. 4e , f), confirming that the reduced TNF-α production was mediated through cDC arginase-2 activity. T reg numbers did not change when arginase activity was modulated, suggesting that fetal dendritic cell regulation of TNF-α production is independent of their promotion of T reg induction (Extended Data Fig. 10e-h ). Further analysis of the supernatants from the co-cultures found that fetal cDC did not downregulate T-cell production of other pro-inflammatory cytokines by arginase-2 activity (Extended Data Fig. 10i -k), suggesting fetal dendritic cells utilize a range of mechanisms to regulate T-cell biology, which remain to be explored. We also found that when fetal cDC were cultured with adult cDC2, they could abrogate adult cDC2 promotion of TNF-α production by T cells (Extended Data Fig. 10l, m) . In addition, when fetal T cells were cultured in the absence of cDC, they produced TNF-α , but when co-cultured with fetal cDC their ability to produce TNF-α was significantly impaired (Fig. 4g) . Altogether, these data confirm that, in the absence of TLR stimulation, fetal dendritic cells promote immune suppression and impair T-cell TNF-α production in response to allogeneic antigens through expression of arginase-2. Importantly, a recent study highlighted the crucial role of l-arginine as major modulator of adult T-cell biology 24 . In summary, our findings have uncovered a previously unknown mechanism of tolerance and immune suppression that is used during gestation by fetal cDC and works in concert with other mechanisms used by fetal natural killer cells 25 and T reg cells 1 . Understanding the mechanisms through which TNF-α production is regulated within the fetus is important, as elevated levels of TNF-α are associated with a number of pregnancy and perinatal complications including recurrent spontaneous miscarriage, gestational diabetes, and necrotizing enterocolitis. Our data suggest that the regulation of l-arginine levels by fetal dendritic cells is important for controlling T-cell TNF-α levels Figure 4 | Arginase-2 + fetal cDC regulate TNF-α production. a, Cytokine production by adult T cells after co-culture for 6 days with fetal or adult cDC2 (n = 5). b, c, Expression of arginase-2 gene (b) and protein (c) in cDC2. d, Splenocyte T-cell TNF-α production. e, f, TNF-α production (red) of stimulated adult T cells, after overnight culture in the absence (day 0) or presence of cDC2 (day 6 of co-culture), with or without additional supplementation of l-arginine or arginase inhibitors (ABH or BEC). e, Representative dot plots. f, Cumulative data. g, TNF-α production from stimulated fetal T cells under indicated culture conditions. Mean ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, Mann-Whitney test. Each data point in the scatter plots represents an individual experiment.
letter reSeArCH 6 6 6 | N A T U R E | V O L 5 4 6 | 2 9 J U N E 2 0 1 7 during gestation, placing fetal dendritic cells as key regulators of TNF-α production that should be investigated as potential therapeutic targets in such situations. In addition, our study demonstrates that fetal cDC are immunologically dynamic and can orchestrate immune responses as early as the second trimester. How TLR stimulation during intrauterine infections can override immune suppression induced by arginase-2-expressing fetal dendritic cells in an allogeneic context remains to be explored. Altogether, these findings highlight that key processes in human immune development and programming in fact begin early during gestation and may have lifelong implications for immune homeostasis 19 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. . This approval allowed the collection of different fetal tissues from women undergoing clinically indicated termination of pregnancies for the study of immune cells. Women gave written informed consent for the donation of fetal tissue to research nurses who were not directly involved in the research, or in the clinical treatments of women participating in the study, as per the Polkinghorne guidelines 26 . This protocol was reviewed on an annual basis by the Centralised Institutional Research Board, including annual monitoring of any adverse events, for which there had been none. All fetal organs for this study (lung, thymus, spleen, MLNs, gut, appendix, liver, tonsil, and skin) were obtained during the second trimester (12-22 weeks EGA). All fetuses were considered structurally normal on ultrasound examination before termination and by gross morphological examination after termination. In total 72 fetuses of 12-16 weeks EGA and 24 fetuses of 17-22 weeks EGA were used for this study. For comparisons across fetal organs the same donors were used, for example for CyTOF data analysis.
Adult tissues (lung, spleen, gut, and skin) were obtained with approval from Singapore Singhealth and National Health Care Group Research Ethics Committees. Cell isolation. Fetal organs were mechanically dispersed and incubated with 0.2 mg ml −1 collagenase (type IV; Sigma-Aldrich) and DNase I (20,000 U ml
; Roche) in Roswell Park Memorial Institute medium (RPMI) with 10% FCS for up to 1 h in a six-well plate. Viability was typically 80-90% measured by DAPI exclusion (Partec). Fetal gut was initially cut longitudinally through the centre, washed extensively in PBS until all inner content (meconium) was removed and the PBS was clear, before mechanical dispersion and digestion as above, for up to 1 h. Adult lung specimens (eight samples from different donors) were obtained from peri-tumoural tissue. Adult skin (20 samples from different donors) was obtained from mammoplasty and breast reconstruction surgery. Adult spleen specimens (eight samples from different donors) were obtained at distal pancreatectomies in patients with pancreatic tumours in the pancreas. Adult lung 27 and skin 8 specimens were prepared as described previously. Adult spleen specimens were prepared in a similar manner to lung. Tissue macrophages and dendritic cells were isolated to 95% purity from freshly digested tissue cell suspensions by fluorescenceactivated cell sorting (FACS) using BD FACSAriaII or III (BD Biosciences). T cells were isolated to 90% purity from adult and fetal spleen by negative selection using T-cell enrichment kits (Miltenyi Biotec) and separated on an AutoMacs by following the manufacturer's instructions. T cells were labelled with 0.2 μ M CFSE (Life Technologies) for 5 min at 37 °C. In all experiments, enriched APC and T cells were from fetal and adult spleen unless stated otherwise. Flow cytometry. Flow cytometry was performed on a BDLSRII and data analysed with FlowJo (Treestar). Antibodies used are listed in Supplementary Table  12 . An eBioscience FOXP3/Transcription Factor Staining Buffer Set (eBioscience/ Affimetrix) was used for intracellular staining of IRF-8, IRF-4, CTLA4, arginase-2, TNF-α , and FOXP3 cells by following the manufacturer's instructions. Mixed lymphocyte reactions. Five thousand sorted cDC from defined subpopulations were co-cultured with 100,000 CFSE-labelled adult or fetal spleen T cells for 6 days in 200 μ l complete RPMI-1640 Glutamax medium (Life Technologies) supplemented with 10% FBS and 1% penicillin/streptomycin 27 . On day 6, cells supernatants (100 μ l) were removed and stored at − 80 °C for detection of the cytokines indicated in Fig. 4a and Extended Data Figs 8f and 10i-k) at a later date. Cytokines were detected using Luminex bead-based multiplex assays, as detailed below. For analysis of intracellular TNF-α production analysis, on day 6 of co-cultures T cells were re-stimulated with 10 μ g ml −1 phorbol myristate acetate (PMA) and 500 μ g ml −1 ionomycin for 1 h at 37 °C. Brefeldin A solution (10 μ g ml ) was added for 4 h. Intracellular cytokine production was determined by flow cytometry. In some experiments on day 0, the arginase inhibitors S-(2-boronoethyl)-l-cysteine (BEC) or amino-2-borono-6-hexanoic acid (ABH) (each used at 30 μ M respectively) were added to co-cultures. In some experiments on day 6, 1 mM l-arginine was added to co-cultures 1 h before stimulation with PMA/ionomycin. Ex vivo co-culture assays. Fetal or adult splenocytes (1 × 10 5 ) were seeded into 96-well round-bottom plates alone or combined at defined ratios in 200 μ l medium. After co-culture overnight or for 6 days, the splenocytes were stimulated with 10 μ g ml −1 PMA (InvivoGen) and 500 μ g ml −1 ionomycin (Sigma) for 1 h at 37 °C. Brefeldin A solution (10 μ g ml ) was added for 4 h. Intracellular T-cell TNF-α production was determined by flow cytometry as described above. Millipore Luminex bead-based multiplex assays on supernatants from mixed lymphocyte reactions. Samples (supernatants) or standards were incubated with fluorescent-coded magnetic beads pre-coated with cytokine-specific capture antibodies. After an overnight incubation at 4 °C with shaking, plates were washed twice with wash buffer. Biotinylated detection antibodies specific to the cytokine of interest were incubated with the complex for 1 h and subsequently Streptavidin-PE was added and the complex incubated for another 30 min. Plates were washed twice again, and beads were re-suspended with sheath fluid before a minimum of 50 beads per cytokine were analysed on a Luminex FLEXMAP 3D (Merck Millipore). Data acquisition used xPONENT 4.0 (Luminex) acquisition software, with data analysed in Bio-Plex Manager 6.1.1 (Bio-Rad). Cytokine concentrations were calculated from the standard curve using a 5PL (5-parameter logistic) curve fit. Drop array Luminex assays on fetal and adult spleen cDC2. Sorted fetal (17-22 weeks EGA) and adult spleen cDC2 were incubated for 18 h at 20,000 cells per well in 100 μ l complete RPMI-1640 Glutamax medium (Life Technologies) supplemented with 10% FBS and 1% penicillin/streptomycin, and stimulated either with TLR agonists (CL075 (1 μ g ml −1
), CpG (3 μ M), PI:C (25 μ g ml −1
), PGN (10 μ g ml −1
), LPS (0.1 μ g ml
)) or with DMSO control. Cells were then pelleted and 95 μ l of supernatants were collected. Fetal and adult spleen cDC2 cytokine production was assessed using Luminex bead-based multiplex assays. Cytokines indicated in the figures were detected with DropArray-bead plates (Curiox) according to the manufacturer's recommendations. Acquisition was performed with xPONENT 4.0 (Luminex) acquisition software, and data analysis with Bio-Plex Manager 6.1.1 (Bio-Rad). Mass cytometry staining, barcoding, acquisition, and data pre-processing. For mass cytometry analysis, purified antibodies were obtained from Invitrogen, Fluidigm, Biolegend, eBioscience, Beckton Dickinson, and R&D Systems using clones as listed in Supplementary Table 13 . For some markers, fluorophore-or biotin-conjugated antibodies were used as primary antibodies, followed by secondary labelling with anti-fluorophore metal-conjugated antibodies (that is, anti-FITC clone FIT-22) or metal-conjugated streptavidin produced as previously described
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. Briefly, cells were plated, stained, and labelled in a V-bottom 96-well plate (BD Falcon). Cells were washed once with 200 μ l FACS buffer (4% FBS, 2 mM EDTA, 0.05% Azide in 1× PBS), followed by staining with 100 μ l of 200 μ M cisplatin (Sigma-Aldrich) for 5 min on ice to exclude dead cells. Cells were then labelled with anti-CADM1-biotin and antibodies in a 50 μ l reaction volume for 30 min on ice. Cells were washed twice with FACS buffer and labelled with 50 μ l heavymetal isotope-conjugated secondary antibody cocktail for 30 min on ice. Cells were washed twice with FACS buffer then once with PBS before fixation with 200 μ l 2% PFA (Electron Microscopy Sciences) in PBS overnight or longer. After fixation, cells were pelleted and re-suspended in 200 μ l 1× perm buffer (Biolegend) and allowed to stand for 5 min at room temperature. Cells were washed once with PBS before barcoding. Bromoacetamidobenzyl-EDTA (BABE)-linked metal barcodes were prepared by dissolving BABE (Dojindo) in 100 mM HEPES buffer (Gibco) to a final concentration of 2 mM. Isotopically purified PdCl 2 (Trace Sciences) was then added to BABE solution to 0.5 mM. Similarly, DOTA-maleimide-linked metal barcodes were prepared by dissolving DOTA-maleimide (Macrocyclics) in L buffer (MAXPAR) to a final concentration of 1 mM. Then, 50 mM of RhCl 3 (Sigma) and isotopically purified LnCl 3 were added to DOTA-maleimide solution to 0.5 mM. Six metal barcodes were used: BABE-Pd-102, BABE-Pd-104, BABEPd-106, BABE-Pd-108, BABE-Pd-110, and DOTA-maleimide-Ln-113. All BABE and DOTA-maleimide-metal solution mixtures were immediately snap-frozen in liquid nitrogen and stored at − 80 °C. A unique dual combination of barcodes was chosen to stain each tissue sample. Barcode Pd-102 was used at 1:4,000 dilution, Pd-104 at 1:2,000, Pd-106 and Pd-108 at 1:1,000, and Pd-110 and Ln-113 at 1:500. Cells were incubated with 100 μ l of barcodes in PBS for 30 min on ice. They were then washed in perm buffer and incubated in FACS buffer for 10 min on ice. Cells were then pelleted and re-suspended in 100 μ l of nucleic acid Ir-Intercalator (MAXPAR) in 2% PFA/PBS (1:2,000), at room temperature. After 20 min, cells were washed twice with FACS buffer and twice with water before a final resuspension in water. In each set, cells were pooled from all tissue types, enumerated, and diluted to a final concentration of 0.5 × 10 6 cells per millilitre for acquisition. EQ Four Element Calibration Beads (DVS Science, Fluidigm) were added at a concentration of 1% before acquisition. Cells were acquired and analysed using a CyTOF Mass cytometer. The data were exported in traditional flow-cytometry-file (.fcs) format and cells for each barcode were deconvolved using Boolean gating. One-SENSE analysis. The automated analysis used the One-SENSE algorithm as described previously 11 . For Fig. 2 and Extended Data Figs 4b and 5b, the lineage dimension included CD1c and SIRPα as cDC2 markers, and CD26 and CLEC9A as cDC1 markers. The marker dimension included all the other non-lineage markers of the CyTOF panel. Frequency heatmaps of indicated markers are displayed for both dimensions. cDC2 clusters (cyan gate) and cDC1 clusters (green gate) for each organ and their marker expression profile are highlighted by the extended gates (representative plots of n = 5). For comparisons across fetal organs, organs from the same donor were used.
letter reSeArCH Microarray analysis. Total RNA was isolated from FACS-purified fetal spleen and skin (17-22 weeks EGA) CD14 + , cDC1, and cDC2 cell subsets, and adult spleen CD14 + , cDC1, and cDC2 cell subsets, with a Qiagen RNeasy Micro kit (Qiagen). Total RNA integrity was assessed using Agilent Bioanalyzer and the RNA integrity number was calculated; all RNA samples had an RNA integrity number ≥ 7.1. Biotinylated complementary RNA was prepared according to the protocol by Epicentre TargetAmp 2-Round Biotin-aRNA Amplification Kit 3.0 using 500 pg of total RNA. Hybridization of complementary RNA was performed on Illumina Human-HT12 Version 4 chips. Microarray data were exported from GenomeStudio software without background subtraction. Expression values were quantile normalized and log 2 -transformed in R (version 3.1.2) with Bioconductor (version 2.26.0) lumi package (version 2.18.0). To generate fetal APC subset gene signatures, one cell subset was compared with other cell subsets pooled using t-test in R. Differentially expressed genes were selected with a Benjamini-Hochberg multiple testing 28 corrected P value of < 0.05. For the adult APC gene expression data, samples were grouped by tissue type, and tissue-specific probes were identified with one-way analysis of variance (ANOVA) and a Benjamini-Hochberg multiple testing corrected P value of < 0.05. Connectivity map analysis as previously described 11 was performed comparing fetal dendritic cell signature gene subsets with the adult APC gene expression data after removal of the tissue-specific probes (see Extended Data Fig. 3 for hierarchical clustering and PCA plots before and after removal of tissue-specific probes). To identify the genes that were highly or lowly expressed in a particular cell subset, we used the single-class rank product method 29 , implemented in the Bioconductor RankProd package (version 2.38.0), and selected the top-and bottom-ranked genes with a percentage of false-positives less than 0.01. The in-house-generated adult and fetal microarray data have been deposited in the Gene Expression Omnibus under accession numbers GSE35457, GSE85305, and GSE85304. Quantitative PCR. Total RNA was isolated from adult or fetal gut and MLN (14-20 weeks EGA) cells with a Qiagen RNeasy Micro kit (Qiagen). Total RNA integrity and concentration was assessed using nanodrop 2000 (Thermoscientific). Total RNA (1 μ g) was reverse transcribed using oligo (dT)18 primer and SuperScript II reverse transcriptase (GIBCO-BRL). CCL19 and CCL21 expression was analysed by quantitative PCR using the following primers: + 5-CCAGCCTCACATCACTCA CACCTTGC-3 and − 5-TGTGGTGAACACTACAGCAGGCACCC-3 for CCL19; + 5-AACCAAGCTTAGGCTGCTCCATCCCA-3 and − 5-TATGGCCCTTTAGG GGTCTGTGACCG-3 for CCL21. CCL19 and CCL21 expression was normalized to the housekeeping gene GAPDH + 5-GCCAAGGTCATCCATGACAACTTTGG-3 and − 5-GCCTGCTTCACCACCTTCTTGATGTC-3. Confocal microscopy. Samples were prepared for confocal microscopy as described previously 15 . Statistical analysis. Statistical analysis used for each experiment is indicated in the figure legends. Each n number represents an individual donor and a separate experiment, apart from CyTOF experiments as indicated in the Extended Data figure legends. No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Data availability. Source data for number(s) are provided with the paper. Sequence data that support the findings of this study have been deposited in the Gene Expression Omnibus under accession numbers GSE35457, GSE85305, and GSE85304. Further data that support the findings of this study are available from the corresponding authors upon reasonable request. + mononuclear cells. Cell abundance was determined in fetal lung and thymus at two time points within the second trimester (12-15 weeks EGA) (circle, lung n = 13, thymus = 9) and 16-22 weeks EGA (square, lung n = 8, thymus n = 8) and compared with adult tissues (triangle, lung n = 8). Mean ± s.e.m. * P < 0.05, * * * P < 0.001, Mann-Whitney test. d, Pseudo-colour images of whole-mount fetal spleen (17 weeks EGA) immunolabelled for CD45 (red), CD1c (blue), and CLEC9A (green). White arrows highlight cDC2 (CD45 + CD1c + CLEC9A − ), white arrowhead highlights cDC1 (CD45 + CD1c + CLEC9A + ). Scale bar, 5 μ m. Representative image of n = 3 experiments shown. Also clearly from the PCA plots (c, d), we can see that before tissue gene removal (c), PC1 is entirely determined by tissue. However, upon tissuespecific probe removal (d), PC1 is now devoted to cell type. We identified these tissue-specific genes by finding differentially expressed genes between the pools of all cells from the different tissues (all spleen versus all skin). (cyan gate) across adult and fetal spleen using CyTOF and One-SENSE algorithm 11 . a, Representative gating strategy used to select input population (red gate) for One-SENSE analysis from fetal (17 weeks EGA) and adult spleen samples. b, Representative data of fetal and adult spleen cDC analysed using the One-SENSE algorithm. The lineage dimension included CD1c and SIRPα as cDC2 markers, and CD26 and CLEC9A as cDC1 markers. The marker dimension included all the other non-lineage markers of the CyTOF panel. Frequency heatmaps of markers expression are displayed for both dimensions. The expression of markers by both adult and fetal spleen cDC1 (green) and cDC2 (cyan) is highlighted with the dashed gates. Representative data from n = 5 donors over two separate experiments. ) for One-SENSE analysis from fetal spleen, thymus, lung, and gut (17 weeks EGA). b, Characterization of cDC1 (green gate) and cDC2 (cyan gate) across fetal lung, spleen, thymus, and gut using CyTOF and One-SENSE algorithm 11 . The lineage dimension included CD1c and SIRPα as cDC2 markers, and CD26 and CLEC9A as cDC1 markers. The marker dimension included all the other nonlineage markers of the CyTOF panel. Frequency heatmaps of markers expression are displayed for both dimensions. The expression of markers by fetal cDC1 (green) and cDC2 (cyan) subsets are highlighted with the dashed gates. Representative data from n = 5 donors over two separate experiments. c, Histograms displaying surface markers differentially expressed across fetal organs (17 weeks EGA) but conserved from fetus to adult. The histograms are generated from CyTOF data (generated as described above). Data are representative of n = 5 donors over two separate experiments. d, Fetal cDC1 (green gate) and cDC2 (blue gate) populations were identified within each organ on the basis of their CD26 and CD1c expression (top panels) by flow cytometry analysis. Using the gates in the top panels to select fetal cDC1 (green contours) and cDC2 (blue contours), intracellular expression of IRF-8 and IRF-4 was determined by flow cytometry. Representative data; n = 3 donors in three experiments. cells  cDC1  cDC1  cDC1  cDC2  cDC2  cDC2   TLR8  CLEC7A  TLR2  TLR4  CD80  CD86  TLR3  CD40  TLR7  CD83  CCR7   2  1  0  -2 -1  Value Fetal spleen Adult spleen b a pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 pg ml -1 + T cells after 6 days of adult spleen pan T-cell co-culture with fetal (black, n = 4) or adult (grey, n = 4) spleen cDC2. Proliferation was measured by CFSE dilution. Mean ± s.e.m. e, Proliferation of isolated adult spleen CD8 + T cells, after co-culture with fetal spleen cDC2 for 6 days. Left, representative histograms showing CFSE dilution by CD8 + T cells on day 0 (grey histogram) compared with day 6 with (red histogram) or without (black histogram) CD4 + T-cell depletion. Right, cumulative data (n = 4). Mean ± s.e.m. * P < 0.05, * * P < 0.01, Mann-Whitney test. f, Fetal spleen cDC1 and cDC2 share immune-suppressive properties. Cytokine detected in co-culture supernatants after T-cell co-culture with fetal cDC1 or cDC2 or adult cDC2 (n = 5). Mean ± s.e.m. Statistical significance represents comparisons between indicated conditions measured by one-way ANOVA, multiple comparisons test. * P < 0.05; * * P < 0.01; * * * P < 0.001; NS, P > 0.05. TGFa  IL10RA  PIK3R6  ERCC3  TAF15  ELK1  HMGB1  AKT1  TAF10  TAF6L  TGFBR2  IL10  IL10RB  HSPA1L  CD36  IL8  ARG2  PTGES3  YWHAH  MAP3K12  SIRT1  CDK7   HSPA4  HSPA8  HSP90AB1  PTEN  PPARGC1B  ALDH2   FKBP4   TAF2 letter reSeArCH Extended Data Figure 9 | Gene expression comparison between fetal and adult APC. a, Heatmap showing the row-based, z-score-normalized gene expression intensities of 3,909 differentially expressed genes between fetal and adult APC. Differentially expressed genes were identified using a t-test with a Benjamini-Hochberg multiple testing corrected P value of < 0.05. The genes and cell populations were clustered using the Pearson correlation distance measure and complete linkage method. b, Ingenuity pathway analysis of the differentially expressed genes, > 1.5-fold change, between fetal and adult APC. Bars indicate the P values (− log 10 ) for pathway enrichment. Orange squares indicate the ratio of the number of up-or downregulated genes mapped to the enriched pathway, to the total number of molecules on that pathway represented by the dashed orange line. The vertical solid orange line corresponds to the > 1.5-fold change threshold. Red arrows highlight pathways involved in DC:T-cell interactions, black arrows highlight pathways associated with iNOS/TNF-α signalling. c, Heatmap of immune-modulatory genes involved in cellular metabolism, immune suppression, and the iNOS/TNF-α signalling. Heatmap shows the row-based, z-score-normalized gene expression intensities. d, e, Microarray (d) and flow cytometry (e) data demonstrating arginase-2 (Arg2) expression by fetal (blue, n = 11) and adult (red, n = 7) APC subsets. Isotype control, grey histogram and square on scatterplot (n = 7). Mean ± s.e.m. f, Fetal and adult cDC2 arginase-2 expression is not mediated by TLR stimulation. Fetal liver and adult spleen cDC2 were sort-purified and stimulated with the indicated TLR agonists or dimethylsulfoxide (DMSO) control for 18 h. cDC2 arginase-2 expression was measured by flow cytometry. Mean ± s.e.m. One-way ANOVA, multiple comparisons test. * * P < 0.01. g, TNF-α (n = 4) and Treg (n = 4 and 6) induction after adult spleen T-cell overnight culture alone or with fetal cDC1 or cDC2 for 6 days. Mean ± s.e.m.
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